Purpose. We report transient ocular wavefront and blood glucose data for one patient with acute type 1 diabetes mellitus after the treatment with insulin has been initiated.
For one patient, we report transient changes in wavefront data for both eyes during the onset and therapy of acute type 1 diabetes mellitus (DB1). The group of metabolic diseases named diabetes mellitus has various variants, where the type 1 classification is characterized by an autoimmune destruction of pancreatic cells. When more than 80 to 90% of these cells are destroyed, DB1 becomes manifest and secretion of the hormone insulin is abandoned. This leads to a chronic hyperglycemia with blood glucose values outside the normal range of some 4 to 6 mmol/l. As a therapy, insulin is injected into the body in adapted intervals to reduce blood glucose values, which have to be controlled on a daily if The onset of DB1 is often correlated with a drastic loss of body weight. After the start of the insulin treatment, the blood glucose level undergoes a drastic decrease from a very high to a normal level during some days. During this phase and the following weeks, transient optical phenomena are frequently reported including blurred vision and shifts of the values of refractive error. There are many investigations on the optical properties of eyes and especially the crystalline lens in patients with diabetes mellitus; see the review articles of Calvo-Marorto et al. 1 and Bron et al. 2 Most of them deal with the long-term steady state after some months of treatment with insulin. 3 5 Additionally, very short-term investigations have been reported where the insulin production was blocked in healthy subjects and an acute hyperglycemia has been induced. 6 Neither in short-nor in long-term investigations a great change in the biometry of the eyes has been reported. 1, 7 However, in the transition period, comparatively large changes in refraction values are well known, as described in the recent studies on transient phenomena by Okamoto et al. 8 and Ebeigbe et al.
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This report focuses on the transition period, which starts at the treatment and ends at the time where optical properties settled to initial values. Our approach is different from the literature in three aspects: (1) optical data were sampled every 3 to 4 days, (2) spatially resolved data of the wavefronts (higher order aberrations) are included, and (3) as a case report we are limited to only one subject, n = 1. By chance, the patient was available for a relatively high number of follow-ups, and the recorded data may shed some light on the optics of the crystalline eye lens. It accounts, according to the study of Charman, 10 most probably for the remarkable changes in the eye's optical system. A physiological explanation for the phenomena, however, is still missing. 1, 8 The otherwise healthy patient of this case report was a 34-year-old man with no known ocular diseases and a myopia (OD 2.75 DS, OS 3.00 DS) in both eyes before the onset of DB1. Nine days after the control of the blood glucose level by insulin was being initiated, we started a series of measurements with 19 follow-ups comprising a time span of 130 days from March 2015 to July 2015. Previous wavefront measurement data from August 2011 serve as baseline data in this study because type 1 diabetes mellitus has not been diagnosed before 2015. Refraction data remained unchanged until at least July 2012, as determined by an optometrist. Written in-formed consent was obtained from the subject after the purpose and nature of the follow-up study had been explained to him.
METHODS
A standard Hartmann-Shack sensor, built in our laboratory, with an illumination wavelength of 785 nm, was used to deter-mine the wavefront aberrations of the patient's eyes. Each measurement averaged the results of 20 images, all taken in an interval of some 400 ms. The eyes were measured under natural conditions without cycloplegia. A head rest, but no bite-bar, was used to stabilize the patient's head. Ambient illumination was reduced to allow for pupil diameters larger than 5 mm in all cases. The wavefront data were represented by Zernike coefficients according to ANSI Z80.28-2010, and all final results were scaled to a pupil diameter of 5 mm. Refraction data for sphere, cylinder, and axis were calculated from second-order Zernike coefficients only, which were rescaled to a pupil diameter of 3 mm. A standard wavelength correction was included to correct the refractive components to the reference wavelength of 555 nm. Higher-order aberrations have not been corrected for the wavelength difference. All measurements were taken after breakfast in the morning between 9 and 12 am.
During 130 days, 912 blood glucose level data were collected with the commercial system Bayer Contour Next. With a mean of seven measurements per day, this data describe short-term variations on the scale of hours. Additionally, three HbA1c values, which represent long-term variations of the blood glucose level on the scale of weeks, were determined at the beginning, in the middle, and near the end of the period of 130 days.
CASE REPORT
Because data are from one patient only, we report our results in a semiquantitative way. We try to focus on qualitative behavior and hope to avoid any suggestion of exactness, which is clearly not there.
Blood glucose levels have been monitored immediately with the step-like onset of the insulin therapy. This date will be called day 0 (zero). On day 4, the patient already suffered from blurred vision and we initiated our study. Wavefront measurements began at day 8; see Fig. 1 . At this time, the blood glucose level had already fallen drastically and had nearly reached its steady-state value. Had there been only a direct, short-term, optical response to blood glucose level, we would have observed hardly any change in the optical properties after day 8.
The data of blood glucose levels show remarkably strong fluctuations with a standard deviation of some 2.5 mmol/l, see Fig. 1 ., where data were averaged over 15 entries, equivalent to 2 days, to prevent an otherwise overcrowded graph. A reliable long-term average is given by the HbA1c values (see Fig. 1 ). Because the strength of the fluctuations was nearly constant over the whole period, there is not much evidence that their influence should be different before or after day 80, when values settled to their baseline. Only systematic and sudden trends of the blood glucose level seem to have an impact on wavefront data. This result was also reported by Huntjens et al.
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During the study, we monitored the wavefront of both eyes. The temporal evolution of the two quantities, equivalent sphere and spherical aberration (Zernike coefficient c 12 = c Z80.28Y2010), show the same parallel qualitative behavior in both eyes; compare Fig. 2 and Fig. 3 . The data for the first 7 days are missing, so the behavior at the very beginning is not included in our data. Nevertheless, the values increase in a surge reaching the maximum some 15 to 20 days after initial treatment with a mean rate of 0.25 D per day. Then a much slower decline, which might be exponential, takes over and some 60 days later, around day 80, baseline values are reached. The mean rate here lies at 0.083 D per day. The decline takes three to four times longer than the increase. The step-like change in insulin supply made its strongest impact more than 2 weeks later and then vanishes slowly. These data are in line with the findings of Okamoto et al.
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The equivalent sphere underwent a hyperopic shift by 5 D in both eyes. Its reversal was nearly perfect and the final differences to baseline values were below 0.15 D. During the manifest changes in refraction, the patient used a trial frame with appropriate test lenses to compensate for his fast changing refractive error. At least at home, he could manage most of his duties. From day 80 onwards, he used his original spectacle frames with his old prescription values without problems.
Cylinder values were below a clinically significant level of 0.5 DC in both eyes at the beginning. They did not exhibit the time dependence of the spherical equivalent, but showed only minor fluctuations. Beside a singular jump of 0.5 DC in the right eye only, on day 15, the cylinder in both eyes remained remarkably stable and kept close to baseline values. The final difference was below 0.1 DC. Axes values where fluctuating by roughly 30°, which is clearly to be expected form a perturbation of very small cylinder values.
Spherical aberration describes the only higher-order rotational symmetric aberration of interest here. Its temporal evolution closely follows the one of the spherical equivalent. Starting from baseline values of OD 0.036 µm and OS 0.062 µm, the spherical aberration increased in positive direction by a factor of 3.5 and 6.7 towards the maximum values of OD 0.24 µm and OS 0.22 µm. Again, baseline values were recovered slightly below ( 0.012 µm), but preserving the initial difference between both eyes. Error bars in Fig. 3 represent the standard deviation and result from slight eye movements, which took place during the image acquisition time of 400 ms for 20 images. Although both eyes display a similar overall time dependence for spherical equivalent and spherical aberration, the left eye peaks some 3 to 5 days earlier than the right eye and then stays ahead. There is a clear setback in spherical aberration on day 15, which might be responsible for the delay.
No other higher-order aberration, say coma or trefoil, showed the typical time-dependence pattern of the spherical aberration. Instead, they displayed a much higher degree of fluctuations. The change of the root of the mean of squares (RMS) values was clearly dominated by the spherical aberration in both eyes. Therefore, the RMS of all higher-order aberrations exhibited a similar increasing and declining phase with similarities to the typical time dependence pattern, but less pronounced. Fig. 4 visualizes the transient process by showing a wavefront profile's evolution, here for the right eye. The crosssection of the wavefront is calculated from its Zernike expansion in a central horizontal meridian (equivalent to axis 180°), excluding the first three terms (piston, tip, and tilt). It is worth mentioning that the mean value of the whole wavefront is zero in all cases because the first term (piston), which has no direct optical meaning, is deliberately chosen as zero. The wavefront profiles measured for the left eye or in different meridians are very similar.
A remarkable change of the parabola-like profiles can be seen in Fig. 4 . The curvature of the profile near the center of the pupil determines the sphere in this meridian. Starting from a myopic eye with a parabola opened to the top, nearly an emmetrope state with a flat profile was reached on day 8. Ten days later, on day 18, the parabola opens downwards, the sign of curvature changes, and the eye was hyperopic. Again, on the way back to the baseline, on day 31, a nearly emmetropic state was passed by. On day 78, the baseline was recovered.
In summary, both eyes underwent heavy transient refractive changes, which appear most prominent in the spherical equivalent and as an increase in spherical aberrations. However, as if the eyes have a "good memory" of their baseline data, after about 80 days, they returned to baseline and recovered their initial values including higher-order aberrations to a high degree of precision. The right eye profile of the wavefront in the horizontal meridian (axis 180°) is shown for selected days, shown as numerals, after initiating the therapy. The profiles are calculated from the Zernike expansion of the wavefront. The mean value of the complete wavefront is zero. The solid line displays the base-line before the onset of type 1 diabetes mellitus. Starting from a myopic eye of -2.75 DS, the evolution showed a hyperopic shift by 5 D and, finally, the resettlement to the baseline. The positive cylinder was below 0.5 DC. The wavefront profiles measured for the left eye or in different meridians are very similar.
DISCUSSION
Although neither the time scale nor the delay in the reaction time of optical properties have a thorough explanation yet, the general nature of the optical changes envisaged can be made plausible by the gradient index structure of the crystalline eye lens. First, Charman identified possible origins of the transient behavior and found the crystalline lens as the dominant factor. 10 Then, in a detailed approach, Charman et al.
12 applied a paraxial model of Bahrami et al. 13 for the gradient index structure. The initial hyperopic refractive shifts of up to a few diopters can be accounted for by reduction in refractive index near the lens center. Additionally, an alteration in the rate of change between center and surface takes place so that most of the index change occurs closer to the lens surface. The appearance of spherical aberration, as measured in our case, complements a lateral structure in the refractive gradient index, which nicely fits in and gives further support to this line of reasoning.
Fourth-order aberrations, like the spherical aberration, can be calculated in the approach of Bahrami et al.
13
as well, showing a similar dominant contribution of the spherical aberration. This effect is amplified if a finite ray tracing procedure is applied, as discussed in the latest version of the model by the same authors.
14 An explanation for the difference in the sign of the aberration coefficient (negative in Bahrami et al.
14 and positive in our data) cannot be given here.
A refined numerical study depends on a basic explanation for the evolution of the spatial refractive index distribution. Here follows a speculative scenario. Before the onset of insulin treatment, an equilibrium of glucose is highly probable in all optical components of the eye because hyperglycemia prevailed for a long time. The insulin treatment rapidly lowers the glucose concentration in the humors, but not in the lens. By osmotic pressure, water might slowly ingress into the lens leading to an increase in the lens' volume. This will diminish the concentration of crystalline proteins. Therefore, the refractive index will decrease at the same rate, accompanied by a diminished power of the lens. The relative changes of the lens thickness and radii are smaller by a factor of three than the relative volume change of the lens. A measurement of such small changes will be difficult.
Because electrolytes constantly enter the lens at the poles, then flow into the nucleus and finally leave the lens at the equator, 15 the water probably will take the same way. A rotational symmetric pattern of the refractive index change will be produced by this mechanism. We can expect the strongest effect in the nucleus, which gradually decreases towards the cortex. Glucose, once it has entered a cell, cannot leave it, but will disappear only by anaerobe consumption. This will be a quite time-consuming process because the metabolism of cells in the nucleus is slow. Nevertheless, the glucose level and the lens volume will finally be back to normal. This scenario might account for the two different time scales and for the rotational symmetric pattern.
Numerical ray tracing can simulate such a scenario. The key point is the modeling of the gradient index structure of the lens. It can be guided by the main observations: a temporal hypermetropia accompanied by a change of spherical aberration. However, such a project lies outside the scope of this case report.
With spherical aberration as the dominant higher-order aberration, decentrations of the pupil will lead to specific changes in lower order Zernike coefficients. A detailed discussion of the various couplings between Zernike coefficients can be found in the work of Lundström et al.
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It is worth noting that spherical aberration will not interact with the trefoil components, but with coma and cylinder. We did not see much changes in trefoil, but fluctuating values in coma. Therefore, it seems quite plausible that decentrations of the pupil with respect to the center of symmetry of the spherical aberration induced the observed fluctuating changes in coma. In other words, if the W-shaped contribution of spherical aberration to the overall wavefront is cut off in an unsymmetrical way, the result always displays induced coma. For a symmetrical pupil position, this part of coma will disappear.
In summary, we emphasize two fundamental observations. First, spherical aberration was the dominant higher-order aberration in our case of acute DM1 transition phenomena. This finding supports the assumption that changes in refractive gradient index structure plays a major role. Second, after 80 days, both eyes recovered the original baseline data to an impressive degree. This is true not only for refraction data but also for higher-order aberrations as well. A measurement of transient phenomena after the onset of insulin treatment in a DM1 patient, which al-ready has an intraocular lens implanted, would clearly enlighten the discussion on the contribution of the crystalline lens.
The recovery of both eyes is difficult to understand as a passive open loop process without any steering control. Which elements of the eye could account for such a task, however, is unknown.
